St. Jude begins coronary artery blockage study

May 27, 2010 by MedCity News

St. Jude Medical Inc. sponsors a clinical study on cost-effectiveness of evaluating coronary artery disease patients with Fractional Flow Reserve.

MedCity News logo

By Brandon Glenn

St. Jude Medical Inc. (NYSE:STJ) will sponsor a clinical study that will evaluate the cost-effectiveness of a method of treating patients with coronary artery disease.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.